3192 results for «832»
3192 results
Mitral valve disease: diagnosis and treatment selection
23 Nov 2021 – From PCR London Valves 2021
In the first part of this PCR London Valves 2021 session, review the quantification of mitral regurgitation and learn how to better approach patients. Then, in the second part, study patient selection for specific types of procedures.
Tricuspid valve disease: state-of-the-art
23 Nov 2021 – From PCR London Valves 2021
Imagine that you are faced with a patient with severe tricuspid regurgitation. You may ask yourself many questions, such as: what could be the prognosis of this patient? What is his/her life expectancy? Is he/she eligible for a particular treatment? What should be the appropriate timing...
Anatomy of the aortic valvar complex with considerations for optimal TAVI positioning
23 Nov 2021 – From PCR London Valves 2021
In this PCR London Valves 2021 simulation-based learning session, learn the latest in transcatheter aortic valve implantation, gain an understanding of anatomical features, review imaging modalities to plan and perform procedures, and witness hands-on activities, among others.
Transcatheter mitral valve repair and replacement: optimal technique and procedural refinement
23 Nov 2021 – From PCR London Valves 2021
This PCR London Valves 2021 interactive learning session is designed to review the basics but also the more advanced and complex procedural steps of transcatheter mitral edge-to-edge repair, as this procedure requires a rigorous and standardized technique that can take time to learn.
Tricuspid valve disease: guidelines and beyond
23 Nov 2021 – From PCR London Valves 2021
Watch this PCR London Valves 2021 session to hear about the latest European guidelines on the management of tricuspid valve disease, understand the details behind these guidelines and how they compare with those elsewhere in the world, and, most importantly, find out how Heart Teams can translate...
Coronary access following TAVI
23 Nov 2021 – From PCR London Valves 2021
Using the anatomy and imaging section and simulators, our experts dissect the case of a typical TAVI patient, an 81-year-old male, former smoker, with hypertension, dyslipidemia, and gastric ulcer, symptomatic of effort dyspnea, with marked left ventricular hypertrophy and all the parameters of severe aortic stenosis,...
Fondazione Ricerca e Innovazione Cardiovascolare completes enrollment in TRANSFORM II RCT, a landmark study comparing MagicTouch SCB vs DES in native coronary vessels
12 Jun 2025
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis
22 Mar 2022
Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022.
Author
INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes
03 Sep 2024
Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.
Author
lmaging: The eyes of the Heart Team
14 May 2024
More than ever, Heart Team members rely on advanced imaging to guide procedures and aid in decision-making about patient selection and management. Just as imaging plays a prominent role in the cathlab, so it will be central to this year's EuroPCR content, with a track of specially...
New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial
29 Mar 2025
Luigi Biasco provides his take on a sub-analysis of the Early TAVR trial about the early and delayed aortic valve replacement implant patients presented by Philippe Genereux at ACC.25 in Chicago.
Author
Top Interventional Trials presented at ACC.21
07 Jun 2021
Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21
Author
